Clinical Trial Update: Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update noting completion of a Phase 2/3 study evaluating late-course accelerated hyperfractionated IMRT for locoregionally advanced nasopharyngea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2, Phase 3 | Status: COMPLETED